[en] Ketoconazole (KET) and zinc pyrithione (ZPT) are compounds active against the Malassezia spp. yeasts, which are believed to play a major role in dandruff and seborrheic dermatitis. We compared the efficacy and safety of KET 2% and ZPT 1% in shampoo formulations for the alleviation of severe dandruff and seborrheic dermatitis. This open randomized, parallel-group trial began with a 2-week run-in phase during which subjects applied a neutral non-antidandruff shampoo. It was followed by a 4-week randomized treatment phase and a subsequent 4-week follow-up phase without treatment. Shampooing during the treatment period was carried out twice weekly for the KET group and at least twice weekly for the ZPT group in accordance with the label instructions. A total of 343 subjects were recruited to enter the trial. Of the 331 eligible volunteers, 171 were randomized to KET 2% and 160 to ZPT 1%. Clinical assessments were performed. Beneficial effects were evidenced for both medicated shampoos, but the effect was significantly better for KET 2%, which achieved a 73% improvement in the total dandruff severity score compared with 67% for ZPT 1% at week 4 (p < 0.02). The recurrence rate of the disease was also significantly lower following KET 2% treatment than following ZPT 1% treatment. As a consequence, the overall clearing of the skin condition at the end of treatment and follow-up phase was in favor of the KET 2% formulation (p = 0.004). Side effects were minimal. It is concluded that after a 4-week treatment, KET 2% shampoo was significantly superior to ZPT 1% shampoo in the treatment of subjects with severe dandruff or seborrheic dermatitis of the scalp. It is our assumption that this difference is noticeable for the patient and as a consequence relevant. Both formulations were well tolerated.
Disciplines :
Dermatology
Author, co-author :
Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Goffin, Véronique ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Decroix, Jacques
Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
English
Title :
A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis.
McGinley KJ, Leyden JJ, Marples RR, Path MRC, Kligman AM: Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975;64:401-405.
Shuster S: The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984;111: 232-242.
Heng MCY, Henderson CL, Barker DC, Haberfelde G: Correlation of Pityrosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990;23:82-86.
Arrese JE, Piérard-Franchimont C, De Doncker P, Heremans A, Cauwenbergh G, Piérard GE: Effect of ketoconazole-medicated shampoos on squamometry and Malassezia ovalis load in pityriasis capitis. Cutis 1996;58:235-237.
Hay RJ, Graham Brown RAC: Dandruff and seborrhoeic dermatitis: Causes and management. Clin Exp Dermatol 1997;22:3-6.
Piérard GE, Arrese JE, Piérard-Franchimont C, De Doncker P: Prolonged effect of antidandruff shampoos: Time to recurrence of Malassezia ovalis colonization of skin. Int J Cosmet Sci 1997;19:111-117.
Piérard-Franchimont C, Arrese JE, Durupt G, Ries G, Cauwenbergh G, Piérard GE: Correlation between Malassezia spp load and dandruff severity. J Mycol Med 1998;8:83-86.
Faergemann J: In vitro and in vivo activities of ketoconazole and itraconazole against P. orbiculare. Antimicrob Agents Chemother 1984; 26:773-778.
Van Cutsem J, Van Gerven F, Fransen J, Schrooten P, Janssen PAJ: The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulphide against pityrosporosis and their efficacy as a shampoo in the treatment of experimental Pityrosporumin guinea pigs. J Am Acad Dermatol 1990;2:933-938.
Nenoff P, Haustein UF: In vitro susceptibility testing of Pityrosporum ovale against antifungal, antiseborrheic and antipsoriatic agents. J Eur Acad Dermatol Venereol 1994; 3:331-333.
Van Gerven F, Odds F: The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: Bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole. Mycoses 1995;38:389-393.
McGrath J, Murphy GM: The control of seborrheic dermatitis and dandruff by antipityrosporal drugs. Drugs 1991;41:178-184
Ermolayeva E, Sanders D: Mechanism of pyrithione-induced membrane depolarization in Neurospora crassa. Appl Environ Microbiol 1999;61:3385-3390.
Cochet P, Levron JC, Caizergues Ph, Bromet-Petit M, Rouzier-Panis R, Cellier F: Kinetics of ketoconazole distribution within the horny layer following a single topically applied 2% monodose foaming gel (shampoo). Nouv Dermatol 1995; 14:607-611.
Marks R, Pearse AD, Walker AP: The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985;112: 415-422.
Loden M, Wessman C: The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo. Int J Cosmet Sci 2000;22:285-289.
Beetens JR, Loots W, Somers Y, Coene MC, de Clerck F: Ketoconazole inhibits the biosynthesis of leucotrienes in vitro and in vivo. Biochem Pharmacol 1986;35:883-891.
Van Cutsem J, Van Gerven F, Cauwenbergh G, Odds F, Janssen PAJ: The anti-inflammatory effects of ketoconazole. J Am Acad Dermatol 1991;25:257-261.
Yoshimura T, Kudoh K, Aiba S, Tagami H: Anti-inflammatory effects of ketoconazole for the inflammation induced on the skin of hairless guinea-pigs by repeated applications of heat-killed spores of M. furfur: A comparative study with hydrocortisone 17-butyrate. J Dermatol Treat 1995;6:113-116.
Artis WM: Final pathway for delivery of oral ketoconazole in keratinized cornified skin; in Meinhof W (eds): Dermatomycoses: A Step Forward. Oxford, Medicine Publishing Foundation, 1985, pp 61-71.
Brown M, Evans TW, Poyner T, Tooley PJH: The role of ketoconazole 2% shampoo in the treatment and prophylactic management of dandruff. J Dermatol Treat 1990;1: 177-179.
Danby FW, Maddin WS, Margesson LJ, Rosenthal D: A randomized, double-blind trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29:1008-1012.
Peter RU, Richarz-Barthauer U: Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: Results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995;132:441-445.